Literature DB >> 1570823

Acceptable values of kappa for comparison of two groups.

D G Seigel1, M J Podgor, N A Remaley.   

Abstract

A model was developed for a simple clinical trial in which graders had defined probabilities of misclassifying pathologic material to disease present or absent. The authors compared Kappa between graders, and efficiency and bias in the clinical trial in the presence of misclassification. Though related to bias and efficiency, Kappa did not predict these two statistics well. These results pertain generally to evaluation of systems for encoding medical information, and the relevance of Kappa in determining whether such systems are ready for use in comparative studies. The authors conclude that, by itself, Kappa is not informative enough to evaluate the appropriateness of a grading scheme for comparative studies. Additional, and perhaps difficult, questions must be addressed for such evaluation.

Mesh:

Substances:

Year:  1992        PMID: 1570823     DOI: 10.1093/oxfordjournals.aje.a116324

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

1.  Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease?

Authors:  Cécile Olivia Muller; Cécile Mignot; Nadia Belarbi; Dominique Berrebi; Arnaud Bonnard
Journal:  Pediatr Surg Int       Date:  2012-04-26       Impact factor: 1.827

2.  Diagnostic value of the preoperatively detected radiological transition zone in Hirschsprung's disease.

Authors:  Xuyong Chen; Wu Xiaojuan; Hongyi Zhang; Chunlei Jiao; Kechi Yu; Tianqi Zhu; Jiexiong Feng
Journal:  Pediatr Surg Int       Date:  2017-02-02       Impact factor: 1.827

3.  Rotator cuff tears: should abduction and external rotation (ABER) positioning be performed before image acquisition? A CT arthrography study.

Authors:  Hubert Cochet; Stephane Couderc; Eric Pelé; Nicolas Amoretti; Marie-Hélène Moreau-Durieux; Olivier Hauger
Journal:  Eur Radiol       Date:  2009-11-05       Impact factor: 5.315

4.  Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area.

Authors:  F Luzza; M Imeneo; M Maletta; G Paluccio; S Nisticò; F Perticone; A Focà; F Pallone
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

5.  The inter-observer reproducibility of Lasègue's sign in patients with low back pain in general practice.

Authors:  H J van den Hoogen; B W Koes; W Devillé; J T van Eijk; L M Bouter
Journal:  Br J Gen Pract       Date:  1996-12       Impact factor: 5.386

6.  Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission.

Authors:  F Luzza; M Imeneo; M Maletta; G Paluccio; A Giancotti; F Perticone; A Focà; F Pallone
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

7.  Prevalence and clinical features of lumbar zygapophysial joint pain: a study in an Australian population with chronic low back pain.

Authors:  A C Schwarzer; S C Wang; N Bogduk; P J McNaught; R Laurent
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

8.  Translating research into practice intervention improves management of acute pain in older hip fracture patients.

Authors:  Marita G Titler; Keela Herr; John M Brooks; Xian-Jin Xie; Gail Ardery; Margo L Schilling; J Lawrence Marsh; Linda Q Everett; William R Clarke
Journal:  Health Serv Res       Date:  2009-02       Impact factor: 3.402

9.  Object-oriented regression for building predictive models with high dimensional omics data from translational studies.

Authors:  Lue Ping Zhao; Hamid Bolouri
Journal:  J Biomed Inform       Date:  2016-03-10       Impact factor: 6.317

10.  Risk of bias versus quality assessment of randomised controlled trials: cross sectional study.

Authors:  Lisa Hartling; Maria Ospina; Yuanyuan Liang; Donna M Dryden; Nicola Hooton; Jennifer Krebs Seida; Terry P Klassen
Journal:  BMJ       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.